RxDoctor Payments Data

Anna Pfenniger, MD

Clinical Cardiac Electrophysiology · Chicago, ILNPI 1912346248

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (56.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Medtronic at 49.2% of the total. Reporting peaked in 2019 at $16,792 and has fallen 94.1% since, to $998 in 2025.

$48,762in general payments, 2019–2025

Across 210 payments — averaging $232.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$24K
  • Abbott$15K
  • Boston Scientific$8K
  • Biosense Webster, Inc.$715
  • Biotronik Inc.$706
  • Altathera Pharmaceuticals LLC$39
  • plus $16 from 1 others

What the payments were for

  • Speaking & faculty fees$4,83110%
  • Grants$27,70857%
  • Travel & lodging$7,49915%
  • Food & beverage$8,30217%
  • Education$4211%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,762 in reported general payments places this provider in the 75th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

See all clinical cardiac electrophysiology providers in Illinois

Medicare billing

Part B allowed, 2024
$59,654
Medicare patients
236
Services billed
527

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban21$33,078
XareltoRivaroxaban18$23,660
Metoprolol Succinate42$614
Flecainide Acetate15$315

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →